Clinical inputs
Understand the result,
not just the number.
MELD-Na (Model for End-Stage Liver Disease including serum sodium): explanation and clinical context The MELD score is a widely validated, laboratory-based model to estimate short-term (90-day) mortality in patients with advanced liver disease; it uses serum bilirubin, INR, and serum creatinine as inputs. The MELD-Na score augments MELD by incorporating serum sodium as an independent predictor of mortality in cirrhosis, improving short-term risk discrimination and allocation priority decisions. In practical implementation the MELD is calculated using natural logarithms of bilirubin, INR, and creatinine with an intercept term; the continuous MELD value is then used in the MELD-Na adjustment.
In the widely adopted formulation derived and validated by Kim et al. (NEJM 2008), serum sodium is bounded (commonly between 125 and 140 mmol/L) before incorporation, and the MELD-Na formula used in this tool is: MELD-Na = MELD − Na − 0.025 × MELD × (140 − Na) + 140. This produces a score with improved sensitivity for short-term mortality compared with MELD alone and has been implemented in allocation policy (OPTN/UNOS) and many clinical calculators. Clinicians should note local policy differences (some sites/registries use slightly different algebraic variants or caps) and that dialysis status (dialysis twice in past 7 days or 24-hr CVVHD) may be handled by substituting a fixed creatinine per allocation rules (e.g., creatinine set to 4.0 mg/dL in those circumstances).
Use MELD and MELD-Na as part of a broader clinical assessment; they are prognostic, not prescriptive.
- Source 1
Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List. N Engl J Med. 2008;359:1017–1026. (MELD-Na formula and sodium bounding). Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium into MELD. Gastroenterology.
- Source 2
(alternative derivation / incorporation of sodium into MELD). Original MELD derivation: Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology.
- Source 3
(original MELD formula). OPTN / UNOS guidance and calculator documentation for MELD/MELD-Na (official allocation implementation notes).
Loading discussion…